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Molecular components of the glomerular filtration mechanism play critical roles in renal diseases. Many of these
components are produced during the final stages of differentiation of glomerular visceral epithelial cells, also known as
podocytes. While basic domain leucine zipper (bZip) transcription factors of the Maf subfamily have been implicated in
cellular differentiation processes, Kreisler (Krml1/MafB), the gene affected in the mouse kreisler (kr) mutation, is known
for its role in hindbrain patterning. Here we show that mice homozygous for the krenu mutation develop renal disease and
that Kreisler is essential for cellular differentiation of podocytes. Consistent with abnormal podocyte differentiation, krenu
homozygotes show proteinuria, and fusion and effacement of podocyte foot processes, which are also observed in the
nephrotic syndrome. Kreisler acts during the final stages of glomerular development—the transition between the capillary
loop and mature stages—and downstream of the Pod1 basic domain helix–loop–helix transcription factor. The levels of
Podocin, the gene mutated in autosomal recessive steroid-resistant nephrotic syndrome (NPHS2), and Nephrin, the gene
mutated in congenital nephrotic syndrome of the Finnish type (NPHS1), are slightly reduced in krenu/krenu podocytes.
However, these observations alone are unlikely to account for the aberrant podocyte foot process formation. Thus, Kreisler
must regulate other unknown genes required for podocyte function and with possible roles in kidney disease. © 2002 Elsevier
Science (USA)
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proteinuria.INTRODUCTION
In the kidney, the glomerular filtration apparatus consists
of several highly differentiated cell types: mesangial cells,
podocytes, and the specialized fenestrated capillary endo-
thelium. Both podocytes and endothelial cells produce the
glomerular basement membrane (GBM), which surrounds
the mesangial cells and the capillaries (Lehtonen et al.,
2000; Li et al., 2000). The mesangial cells provide structural
support to the capillaries located immediately adjacent to
1 These authors contributed equally to this work.
2 To whom correspondence should be addressed. Fax: (416) 586-16them. The podocytes, or visceral glomerular epithelial cells,
produce long slender cellular processes, known as pedicles
or foot processes, that wrap around the GBM encased
capillary and together with the GBM form a blood filtration
barrier that maintains selective permeability to proteins.
Damage to podocytes causes renal diseases, such as
minimal change nephrosis (MCNS) or focal segmental glo-
merulosclerosis (FSGS). Aside from diabetes, FSGS is cur-
rently the main cause of renal insufficiency in humans.
Kidney disease is often progressive. At the onset of renal
pathogenesis, the GBM thickens and podocytes assume
ultrastructural characteristics of less mature glomeruli. In
glomerulosclerosis, mesangial cells and an apparently
thickened GBM expand and begin to displace damaged8588. E-mail: cordes@mshri.on.ca.
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podocytes, which have a dedifferentiated appearance, and
ultimately kidney failure results. Such dedifferentiation of
podocytes and loss of the molecular components of the
filtration apparatus are associated with genetic renal dis-
eases (Kriz et al., 1994; Pagtalunan et al., 1997). Recent
advances in human genetics further underscore the impor-
tance of the podocyte. Mutations in genes that encode
components of the specialized podocyte cytoskeleton can
cause genetic renal disease. In mice and humans, the
expression of these genes is highly podocyte-specific and
must be regulated by podocyte-specific differentiation fac-
tors. However, only a few transcription factors with roles in
glomerular development have been identified, and even
fewer are known to regulate podocyte differentiation spe-
cifically (Lechner and Dressler, 1997). The identification of
regulatory molecules that could reactivate proper expres-
sion of the key structural components of the podocytes, the
filtering pedicles, and the GBM would be necessary to
resuscitate injured podocytes or induce development of new
ones.
Members of the Maf subfamily of basic domain leucine
zipper transcription factors play key roles in cellular differ-
entiation (Blank and Andrews, 1997). Loss-of-function mu-
tations in mouse c-Maf and MafG interrupt terminal differ-
entiation of lens fiber cells and megakaryocytes,
respectively (Kim et al., 1999; Ring et al., 2000; Shavit et
al., 1998). Furthermore, potential binding sites for Maf
protein homodimers or heterodimers have been found in
the promoters of important cell type-specific genes, such as
-globin, heme oxygenase, interleukin-4, and crystallins,
and expression of these genes can be regulated by specific
Maf proteins in transient transfection assays (Inamdar et
al., 1996). In contrast to other Maf family members, Kreisler
(Krml1/MafB; known as MafB according to mouse nomen-
clature) is known for its role in embryonic patterning rather
than any functions in cellular differentiation. Kreisler was
originally identified as the gene affected in the kreisler (kr)
mouse mutation, in which a primary defect in embryonic
hindbrain patterning causes circling behavior and deafness
in kr/kr adults (Cordes and Barsh, 1994; Deol, 1964). The
embryonic hindbrain is transiently subdivided into seven to
eight segments, known as rhombomeres. Kreisler is ex-
pressed transiently in the fifth and sixth rhombomeres
during hindbrain segmentation (Cordes and Barsh, 1994). In
animals with mutations in Kreisler, the fifth and sixth
rhombomeres do not form properly and rhombomere-
specific expression of Hox genes is disrupted in r5 and r6
(Cordes and Barsh, 1994; Manzanares et al., 1997, 1999;
Moens et al., 1998). In the mouse, there are two mutant
alleles of Kreisler: the viable X-ray-induced kr allele and the
FIG. 1. Mice homozygous for the krenu mutation die as neonates. (A) A schematic diagram shows the novel EarI recognition site generated
by the krenu mutation in the DNA-binding domain of Kreisler and the location of primers used to amplify this region. (B) EarI digestion of
the PCR product from normal Kreisler results in a 416-bp undigestable fragment present in / and /krenu mice, while EarI digestion of
the PCR fragment generated from krenu DNA yields 289- and 127-bp fragments present in krenu heterozygous and homozygous animals. (C)
The table shows the genotypes of complete litters from krenu/ intercrosses at various stages of development. No decrease in viability of
krenu/krenu embryos was observed throughout embryogenesis or at birth. However, within 24 h after birth, all krenu/krenu mice have died. No
weanling or adult krenu homozygotes have ever been recovered. Only complete litters harvested are shown here. Additional krenu
homozygotes and normal littermates were harvested at 14.5 and 15.5 dpc and as neonates for the experiments performed here.
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lethal krenu allele, which we generated previously by chemi-
cal mutagenesis with ethylnitrosourea (ENU). The unex-
pected lethality of krenu homozygotes suggested that further
analysis of the phenotypes of mice homozygous for the krenu
allele would reveal additional essential functions of the
Kreisler gene, possibly in cellular differentiation. Here we
show that Kreisler is required specifically for podocyte
differentiation.
MATERIALS AND METHODS
Mice and Genotyping
Fifteen CSJ/L male mice, which are homozygous for the A allele
of the agouti coat color locus, were mutagenized with four weekly
doses of 100 mg/kg ENU (Sigma). Upon recovery of fertility at
10–12 weeks postinjection, mutagenized males were bred to a kr/A
Kr females, which had been maintained on the C3H/HeJ strain for
more than 10 generations. We recovered 3 circling mice upon
screening 597 weanling mice (Cordes and Barsh, 1994). Deafness
was initially scored by lack of the Preyer’s reflex. To determine
whether the krenu mutation could be a new allele of Kreisler, we
tested whether this mutation is linked to the agouti coat color
locus. The original A krenu/a kr male recovered from this screen was
bred to C57Bl/6J females; only the resulting Agouti female off-
spring had deaf, circling progeny when mated to a kr/a kr males.
Only in the presence of the original kr allele do animals carrying
the krenu mutation exhibit the characteristic circling and deafness.
As described previously, we determined that the krenu mutation
indeed represents a new allele of Kr. The original A krenu/a kr male
recovered from this screen and subsequent A krenu/a heterozy-
gotes have been crossed onto a C57Bl6/J background for more than
10 generations. For unambiguous determination of genotype, we
developed a PCR assay that relies on an EarI polymorphism
generated by the A-to-G transition in the krenu allele. The basic
domain leucine zipper region of Kreisler was amplified with
primers 5-GCAGAATAGGGAGTCTG and 5-AAGGATCCGG-
ACCGCTTCTCTGAGAC by 40 cycles of denaturing at 94°C,
annealing at 54°C, and extending at 72°C for 1 min each. Digestion
of the resulting 416-bp product with Ear1(New England Biolabs,
FIG. 2. Defects in appearance and function of neonatal kidneys from krenu/krenu mice. Unlike kidneys from/krenu neonates (A), those from
krenu/krenu neonates (B) have a punctate cortical surface and slightly shrunken appearance. (C) Kreisler is expressed at high levels in
podocytes of 14.5-dpc kidneys as detected by digoxigenin RNA in situ hybridization on sections. The scale bar represents 100 m. (D)
Kreisler continues to be expressed in podocytes (pc) of weanling mice as shown here by dideoxygenin RNA in situ hybridization on sections
from a 3-week-old krenu/ mouse. In the kidney, Kreisler expression could only be detected in podocytes, which in sections are organized
in a characteristic crescent shape at the outer edge of glomeruli. Kreisler expression could not be detected in comma-shaped (cs)- and
S-shaped-stage glomeruli (ss) located near the cortical surface in the nephrogenic zone (nz), but only in the podocytes of the more internally
located capillary loop stage or mature glomeruli. The scale bar represents 20 m. (E) krenu/krenu neonates exhibit proteinuria. In lane 1, no
protein could be detected in 0.1 l of urine from heterozygous neonates on a Coomassie blue-stained 10% polyacrylamide minigel.
However, in lane 2, significant amounts of an 67-kDa protein, which is consistent with the expected size of serum albumin, could be
detected in 0.1 l of urine from krenu/krenu neonates. Lane 3 shows protein markers of the sizes indicated in kDa.
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FIG. 3. krenu/krenu neonatal kidneys are histologically indistinguishable from / and/krenu kidneys. Sagittal sections of /krenu (A) and
krenu/krenu (B) neonatal kidneys stained with hematoxylin and eosin do not reveal any histological abnormalities The nephrogenic zone (nz),
the birthplace of all glomeruli, is located on the outer rim of the cortex. Mature glomeruli are located more internally. Proximal (pt) and
distal tubules are clearly visible just below the nephrogenic zone and are well-organized. The stroma (s) appears normal. Sagittal sections
of mature glomeruli from /krenu (C) and krenu/krenu (D) kidneys stained with toluidine blue show no abnormalities. Capillaries (c) and all
glomerular cell types are present and appear morphologically normal. Podocytes (pc) are in normal positions and appear normal at this
magnification. The scale bar in (A) indicates 60 m, while that in (C) represents 20 m. (B) is at the same magnification as (A), and (C) is
at the same magnification as (D). (E–H) Lack of normal podocyte foot processes in krenu/krenu glomeruli. Electron microscopy reveals that
all glomerular cell types—mesangial and endothelial cells as well as podocytes—are present in normal (E, G) and krenu/krenu (F, H) glomeruli.
However, there are significant ultrastructural differences between glomeruli from krenu/ (E, G) and krenu/krenu (F, H) neonates. Discrete foot
processes can be seen in normal glomeruli (E, G). In (F,H), krenu/krenu mice podocyte foot processes (fp) are fused and do not interdigitate.
Where these foot processes should be located is indicated with “fp” in parentheses. (E, F) Lower magnification views. The scale for these
panels is shown in (E) and represents 2 m. Higher magnification shows that, while podocyte foot processes are absent, the GBM of krenu/
(G) and krenu/krenu (H) glomeruli appear indistinguishable. The scale for (G, H) is shown in (G) and represents 1 m. E, erythrocytes; gbm,
glomerular basement membrane; M, mesangial cells; pc, podocyte; fp, podocyte foot process.
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Beverly, MA) results in 289- and 127-bp fragments diagnostic for
the krenu allele. In addition to the whole litters collected and
tabulated in Fig. 1C, 21 krenu/krenu mice and corresponding 26 /
and 27 /krenu littermates were collected for phenotypic analyses
described.
Phenotypic Analysis
Urinanalysis. Urine was expressed from neonatal mice be-
tween 6–24 h after birth and analyzed by spotting onto Multistix 8
SG Reagent strips for Urinanalysis (Miles Inc., Diagnostics Divi-
sion, Elkhart, IN). Then, 60 s after “spotting,” the urine was
analyzed for the presence of protein by comparison with the
standardized chart. Urine from normal littermates (krenu/ and
/) and from kr/kr mice contained approximately 30 mg/dL of
protein, while that from krenu homozygous neonates contained
between 100 and 300 mg/dL. For protein analysis, 0.1 l of urine
from mutant and normal neonates was examined by electrophore-
sis on a 10% denaturing SDS–polyacrylamide minigel.
Analysis of Expression Patterns
Whole-mount RNA in situ analysis was performed as previously
described by using sense and anti-sense probes generated from 1183
to 1411 of the Kreisler 3UTR, and probes for Hoxa3, Hoxb3, and
Hoxd3 (Cordes and Barsh, 1994; Frohman et al., 1993; Manley and
Capecchi, 1998). Sense and anti-sense probes for Nephrin and Pod1
were generated as previously described (Quaggin et al., 1999; Wong
et al., 2000). Sense and anti-sense probes for Podocin (GenBank
Accession No. AI552534) and CD2AP (GenBank Accession No.
AA739155) were generated from ESTs obtained from the
I.M.A.G.E. clone consortium (Genome Systems, Inc., Berkeley,
MO). The CD2AP and Podocin anti-sense probes were generated by
digestion of the plasmids with EcoRI and transcription with T3
RNA polymerase. To generate sense probes for CD2AP and Podo-
cin, the EST clones were digested with NotI and subsequently
transcribed with T7 RNA polymerase.
For digoxigenin RNA in situ hybridization on sections, embryos
were fixed in 4% paraformaldehyde overnight and embedded in
O.C.T. Tissue-Tek embedding medium (Sakura Finetechnical Co,
Ltd., Tokyo, Japan). Then, 12-m sections were cut with a Leica
CM3050 cryostat. Hybridizations were performed essentially as
described in Storm and Kingsley (1996).
For histological analyses, tissues and embryos were fixed in 4%
paraformaldehyde on phosphate-buffered saline overnight and em-
bedded in paraffin. Then, 8- to 12-m sections were cut with a
microtome (Leica) and stained with hematoxylin and eosin. For
electron microscopy, tissues were fixed in 2% glutaraldehyde in
phosphate-buffered saline, and transmission electron microscopy
was performed by standard methods.
For immunohistochemistry, a rabbit anti-Kreisler antibody was
raised against Maltose-binding protein fused to a full-length
Kreisler protein, which has been used in previous binding studies.
Immunohistochemistry using this anti-Kreisler antibody was per-
formed on 12-m cryosections, which had been postfixed in 4%
paraformaldehyde, rinsed in PBS, and blocked in 10% goat serum.
Sections were incubated overnight with primary antibody at a
1:5000 dilution at 4°C, rinsed three times in PBS, and incubated at
room temperature for 1 h with Cy3-donkey anti-rabbit IgG (Jackson
ImmunoResearch Laboratories, Inc., West Grove, PA). Slides were
once again rinsed three times in PBS and examined microscopi-
cally. Immunohistochemistry with anti-Laminin 2, anti-Integrin
3, anti-Podocin, anti-Nephrin, and anti-PCNA (Chemicon Inter-
national, Inc., Temecula, CA) antibodies was performed as previ-
ously described (Holzman et al., 1999; Kreidberg et al., 1996;
Noakes et al., 1995; Sasaki et al., 2002; Schwarz et al., 2001).
The RNA levels of Podocin, Nephrin, and  Actinin 4 were
determined by RNA slot blot analyses. Two separate experiments
were performed on three independent sets of RNA samples. RNA
levels were quantified by using the Scion Image suite of programs
to analyze the resulting autoradiographs. Amounts were standard-
ized relative to the level of GAPDH present in each sample.
RESULTS
Neonatal Lethality of krenu/krenu Homozygotes
The krenu mutation was identified in a noncomplementa-
tion mutagenesis screen by the circling behavior and deaf-
ness of kr/krenu mice. However, no circling deaf mice have
ever been recovered from krenu/ intercrosses (Cordes and
Barsh, 1994). We used an EarI restriction site, which was
created by the A-to-G transition responsible for the krenu
mutation, in a polymerase chain reaction-based assay to
unambiguously identify krenu/krenu and krenu/ mice (Figs.
1A and 1B). We observed the expected Mendelian ratios of
/, krenu/, and krenu/krenu animals at all stages of embry-
onic development and at birth. krenu heterozygotes appeared
indistinguishable from normal animals (Fig. 1C). Even
though many krenu/krenu neonates suckled initially, all died
severely dehydrated within 24 h of birth.
Several observations suggested that hindbrain-
independent developmental roles of Kreisler must be re-
sponsible for the lethality of krenu/krenu neonates. First,
during later embryonic stages and throughout adulthood,
Kreisler is expressed in a wide range of tissues in a cell
type-specific manner. In the original viable kr mutation, a
submicroscopic chromosomal inversion abrogates Kreisler
expression in the fifth and sixth rhombomeres of the
embryonic hindbrain. All other domains of Kreisler expres-
sion examined in 8.5- to 11.5-, 14.5-, and 15.5-dpc embryos
and in adult tissues by RNA in situ and Northern hybrid-
ization were equivalent in normal and kr/kr animals (data
not shown) (Eichmann et al., 1997). Secondly, the defects in
hindbrain patterning are less severe in krenu/krenu than in
kr/kr embryos (V.S.S., A. Sing, L. Mar, F.J., and S.P.C.,
unpublished observations). Finally, we have shown previ-
ously that Kreisler activates transcription of Hoxb3 in the
fifth rhombomere directly (Manzanares et al., 1997).
Kreisler-dependent transcription of Hoxb3 in the fifth
rhombomere cannot be detected in either kr/kr or krenu/krenu
embryos (S.P.C., unpublished observations; Frohman et al.,
1993). Thus, transcriptional activation that depends on the
presence of active Kreisler homodimers appears to be abro-
gated or severely reduced in krenu homozygotes
Morphologic Abnormality of krenu/krenu Kidneys
We observed a variety of morphologic abnormalities,
which include enlarged ventricles in the brain and abnor-
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mal kidneys, that in concert would compromise neonatal
viability of krenu/krenu neonates. Most strikingly, krenu/krenu
neonates can be readily distinguished from normal and
heterozygous littermates by the appearance of their kidneys
(Figs. 2A and 2B). Kidneys from krenu/krenu homozygotes
appear shrunken and have punctate cortical surfaces with
obvious superficial areas of hemorrhaging (Fig. 2B). Within
the kidney, Kreisler expression commences specifically in
glomeruli at 14.5 dpc and is maintained in adults (Figs. 2C
and 2D). The renal vesicle, from which the nephron arises,
proceeds through four morphologically identifiable and
defined developmental stages: the vesicle or comma-shaped
body, the S-shaped body, the capillary loop, and the mature
stages (Abrahamson, 1991). Kreisler mRNA is not detected
in glomeruli at the comma- or S-shaped stages, which are
located near the outer margin of the cortex in the nephro-
genic zone (Figs. 2C and 2D) (Eichmann et al., 1997; Imaki
et al., 2000). Kreisler is expressed exclusively in the podo-
cytes of the more internally located capillary loop-stage and
mature glomeruli. Because members of the Maf subfamily
of bZip transcription factors, such as Kreisler, play key roles
in cellular differentiation, we examined kidneys from krenu
homozygotes further for possible defects in podocyte differ-
entiation.
Renal Function in Neonatal krenu/krenu Mice
To further evaluate renal function in krenu/krenu mice, we
carried out a series of clinical laboratory and histologic
studies. A standard urinalysis revealed an absence of uri-
nary sediment but the presence of proteinuria and occa-
sional hemoglobin. Quantitative analysis showed protein-
uria in the range of 100–300 mg/dL (krenu/, kr/, or kr/kr
animals were 30 mg/dL). Because suckling and food intake
is limited in krenu/krenu neonates, the protein load on the
kidneys is relatively low and conceivably proteinuria would
be more extreme if this protein load was increased. There
are several possible causes for proteinuria and the type of
protein released is indicative of the cause. The presence of
high levels of albumin in the urine is diagnostic of glomer-
ular proteinuria, while defects in the tubular epithelium
lead to presence of small proteins. Finally, overload protein-
uria results in the accumulation of immunoglobin chains in
urine. Analysis of urine from neonates by polyacrylamide
gel electrophoresis revealed the presence of high levels of an
67-kDa protein, which is consistent with the size of
serum albumin (67 kDa) and is characteristic of a glomer-
ular protein leak (Fig. 2E). Therefore, the krenu mutation
must cause a defect within the glomerulus and possibly the
podocytes themselves.
Podocyte Foot process Fusion in krenu/krenu Kidneys
Standard histologic analysis revealed no gross malforma-
tions at any stage of kidney development in krenu/krenu
animals (Figs. 3A–3D). The nephrogenic zone, which is
located near the external surface of the cortex and in which
glomerular development begins, appeared normal in krenu/
krenu animals. The stroma, proximal and distal tubules,
ureter, and organization of nephrons in krenu/krenu kidneys
appeared indistinguishable from those in normal kidneys
(Figs. 3A and 3B). We had initially noticed the shrunken and
spotted appearance of kidneys in krenu homozygotes. In
mice homozygous for mutations in either PDGF or the
PDGF receptor, a “spotted kidney” phenotype is seen and
is caused by the absence of mesangial cells and abnormal
vasculogenesis (Hellstrom et al., 1999; Leveen et al., 1994;
Soriano, 1994). However, in krenu/krenu animals, mesangial
cells and capillaries within glomeruli themselves are
present and appear ultrastructurally normal (Fig. 3). Fur-
thermore, no hemorrhaging or accumulation of blood is
seen within glomeruli. Podocytes appear histologically nor-
mal as well (Figs. 3C and 3D). Finally, no defects in
branching morphogenesis of the uretary bud epithelium of
13.5- or 15.5-dpc kidneys were detected by DBA–lectin
staining (data not shown).
A glomerular protein leak, such as that observed in krenu
homozygotes, is most often caused either by defects in the
formation or maintenance of the glomerular basement
membrane or by effacement of podocyte foot processes.
Therefore, we examined neonatal krenu/krenu kidneys for
ultrastructural defects by electron microscopy (Figs. 3E–
3H). In the normal glomerulus, the podocyte and the GBM
are responsible for maintaining the filtration slit structure
that prevents protein escaping from the capillaries. The
podocyte performs these functions by virtue of a complex
array of interdigitating foot processes, or pedicles, that
create the large intercellular surface area required for glo-
merular filtration and are located distant from the podocyte
cell body. During the early capillary loop stage, when
Kreisler expression is first observed, the epithelial cyto-
plasm appears as a continuous, uninterrupted mass without
any foot processes (Abrahamson, 1991; Kriz et al., 1994). As
podocyte differentiation proceeds, the epithelium begins to
interdigitate until the glomerular basement membrane is
completely fringed by fully formed and distinct pedicles.
Electron microscopy did not uncover any defects in the
GBM. However, in krenu homozygotes, podocytes were
present, but podocyte foot processes were absent or “fused”
(Figs. 3E–3H). The epithelial cytoplasm is continuous and
uninterrupted, and in essence, the podocytes in mature krenu
glomeruli appear to be arrested in the capillary loop stage of
normal development.
Podocytes Form Normally in Kidneys from krenu
Homozygotes
At times, point mutations can compromise either protein
stability or protein localization. To examine whether
Kreisler protein was expressed at normal levels and within
the nucleus of mutant podocytes, we performed immuno-
fluorescence with an antibody raised against full-length
mouse Kreisler protein (Figs. 4A and 4B). These immuno-
fluorescence experiments detected nuclearly localized Kre-
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FIG. 4. Kreisler protein is present in krenu homozygotes, but absent in Pod1/ kidneys. Immunofluorescence detects Kreisler protein in
the nuclei of podocytes of / (A) and krenu/krenu (B) mutant neonatal kidneys at the capillary loop stage. Immunofluorescence with an
anti-Integrin 3 antibody detects equivalent expression in the podocytes of normal (/) (C) and krenu/krenu (D) neonatal kidneys. Laminin
2 is present in the GBM of normal (/) (E) and krenu/krenu (F) glomeruli. PCNA cannot be detected in podocytes of / (G) and krenu/krenu
(H) neonatal kidneys at the capillary loop stage. Autofluorescence of erythrocytes is seen in both (G) and (H). (I) The DAPI counter-stained
/ glomerulus seen in (G). (J) The DAPI counter-stained krenu/krenu glomerulus seen in (H) is shown. (L) Autofluorescence of erythrocytes
can be seen in the absence of anti-PCNA antibody, as shown here in a / glomerulus. The DAPI counter-stained glomerulus for (L) is
shown in (K). Scale bars represent 20 m. Each pair of panels is shown at the same magnification in normal and mutant animals.
FIG. 5. Expression of podocyte-specific genes in normal and mutant kidneys. Digoxigenin RNA in situ hybridization experiments were
performed on cryosections from / (A, C, E, G, K) and krenu/krenu (B, D, F, H, L) neonatal kidneys. -Actinin 4 is expressed in normal (A)
and mutant (B) animals starting at the S-shaped stage. S-shaped-stage glomeruli are outlined with a dashed line. Nephrin is expressed at
equivalent levels in podocytes of normal (C) and krenu/krenu (D) neonatal kidneys. CD2AP is expressed in both / (E) and krenu/krenu (F)
podocytes. Podocin expression appears slightly lower in krenu/krenu (H, J) podocytes than in normal (G, I) podocytes. Pod1 is expressed
equivalently in / (K) and krenu/krenu (L) neonatal kidneys. Experiments were performed on 15.5-dpc and neonatal kidneys. Neonatal
kidneys are shown here. All experiments were performed in triplicate on independent /, /krenu, and krenu/krenu kidneys. Scale bars
represent 20 m in all panels except for (I) and (J). In (I) and (J), the scale bars represent 100 m.
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isler protein at equivalent levels in normal and mutant
podocytes at the capillary loop stage. Thus, the krenu muta-
tion does not destabilize Kreisler protein.
The basal membrane of podocyte foot processes (the
“sole”) attaches to the extracellular matrix of the GBM
(Abrahamson, 1991). Numerous proteins, including Inte-
grin 31, are localized to the “soles” of podocyte foot
processes and are essential for the maturation of podocytes.
Integrin 3-deficient mice, for instance, do not form foot
processes (Kreidberg et al., 1996). In krenu/krenu podocytes,
Integrin 3 is expressed and localized to the cell membrane
much as in normal podocytes as detected by immunofluo-
rescence with anti-Integrin 3 antibody (Figs. 4C and 4D).
The “soles” of the podocyte foot processes attach to the
GBM, and defects in the GBM can cause podocyte foot
process effacement. In vivo labeling and ultrastructural
studies indicate that dual membranes produced by the
podocyte and the glomerular endothelial cells fuse to form
the GBM during the capillary loop stage. In mice lacking
Collagen IV or Laminin 5, defects in the ultrastructural
appearance of the GBM coincide with the fusion and loss of
podocyte foot processes (Cosgrove et al., 1996; Lu et al.,
1999; Miner and Li, 2000). In the absence of some GBM
components, such as Laminin 5, an intact GBM is never
formed, and hence, podocyte foot processes can never
attach to the GBM. Other molecules, such as Collagen
COL4A3, and Laminin 2, appear to be required not for the
initial formation of the GBM, but for its maintenance. For
example, at birth, both the GBM and podocyte foot pro-
cesses appear normal in mice lacking either Col4A3 or
Laminin 2. GBM defects and pedicle loss only become
apparent at 4 weeks of age in mice with loss-of-function
FIG. 6. Nephrin and Podocin are expressed at slightly lower levels in neonatal krenu/krenu kidneys. (A) Levels of mRNA of murine
homologues of kidney disease genes were examined by RNA slot blot analysis. Each well contains 10 g of total RNA from the following
tissues: lane 1, neonatal / kidney; lane 2, neonatal krenu/ kidney; and lane 3, krenu/krenu neonatal kidney. Nephrin, Podocin, and 
Actinin 4 are all expressed in normal, heterozygous, and homozygous krenu mice. (B) Densitometry was used to quantify RNA levels. Levels
of Podocin and Nephrin were slightly lower in kidneys from krenu/krenu animals relative to their / and krenu/ littermates. Levels of 
Actinin 4 are approximately equivalent in normal and mutant kidneys. (C–F) Localization of Podocin and Nephrin proteins was examined
by immunofluorescence. Podocin protein is present in podocyte membranes from normal (/) (C) and krenu/krenu (D) kidneys as detected
by immunofluorescence with an anti-Podocin antibody. Nephrin is localized to the membranes of normal (E) and krenu/krenu (F) podocytes
as detected with immunofluorescence with an anti-Nephrin antibody. The scale bar represents 20 m. All panels are shown at the same
magnification.
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mutations in collagen COL4A3, a mouse model for human
autosomal Alport syndrome, and at 2 weeks in mice lacking
Laminin 2 (Cosgrove et al., 1996; Noakes et al., 1995).
In krenu/krenu kidneys, the GBM appears normal when
examined by transmission electron microscopy (Figs. 3G
and 3H). Notably, at present, only in mice lacking Laminin
2 is foot process effacement observed prior to any visible
ultrastructural abnormalities in the GBM. In all other
known “GBM” mutants, foot processes appear normal as
long as the GBM appears ultrastructurally intact, as it does
in krenu/krenu kidneys. Laminin 2, which is expressed
starting at the capillary loop stage, can be detected in the
GBM of both normal and mutant glomeruli by immunoflu-
orescence (Figs. 4E and 4F). Current analyses of mouse
mutants in GBM components have not identified any single
mutation with a phenotype identical to that observed in
krenu/krenu glomeruli.
Previously, disruption of the cMaf gene has been shown
to arrest differentiation of lens fiber cells. The absence of
cMaf protein results in the failure of lens fiber cells to
withdraw from the cell cycle (Ring et al., 2000). In krenu
homozygotes, we did not detect mitotic figures in any
podocytes examined by transmission electron microscopy.
Furthermore PCNA is expressed in actively dividing cells,
but cannot be detected in podocytes from either normal or
krenu/krenu neonates by immunofluorescence (Figs 4G–4J).
Thus, in contrast to lens fiber cells in cMaf knock-outs,
krenu/krenu podocytes do not re-enter the cell cycle inappro-
priately. These observations suggest that the krenu mutation
disrupts the ability of Kreisler to transcribe molecules
required specifically for podocyte differentiation, but does
not affect any potential role that the Kreisler protein may
play in cell cycle withdrawal during podocyte differentia-
tion.
Expression of Murine Orthologues of Human
Kidney Disease Genes in krenu/krenu Podocytes
Recently, advances in human genetic kidney diseases
have identified additional molecules required for podocyte
function and the formation or maintenance of pedicles.
Mutations in ACTN4, the gene encoding -Actinin 4, cause
dominant familial focal segmental glomerulosclerosis
(FSGS) (Kaplan et al., 2000). -Actinin 4 is an actin filament
cross-linking protein thought to regulate the actin cytoskel-
eton of podocytes. In vitro the dominant mutations identi-
fied in familial FSGS bind filamentous actin more tightly
than normal -Actinin 4 protein does. It is not known
whether -Actinin 4 is required to maintain foot processes
and the slit diaphragm or whether increased rigidity of the
foot processes might make them more vulnerable to dam-
age. Expression of -Actinin 4 commences in podocytes of
the late S-shaped body and early capillary loop stages well
before that of Kreisler. We examined expression of murine
-Actinin 4 in krenu/krenu kidneys by RNA in situ hybridiza-
tion and RNA slot blot analyses. We found no difference in
the temporal and spatial expression nor in the level of
expression of -Actinin 4 between normal and krenu/krenu
kidneys (Figs. 5A, 5B, and 6A). Thus, although it is possible
that Kreisler acts in parallel with the genes that regulate
-Actinin 4, we believe that Kreisler acts at a slightly later
stage, and in the future may serve as a marker for the
mid-capillary loop to mature stages.
A highly unique feature of podocyte foot processes is the
presence of the “slit diaphragm.” The slit diaphragm is
inserted between foot processes just above their “sole” and
thus joins podocyte foot processes laterally. A complex that
contains three known proteins, Nephrin, Podocin, and CD2
adapter protein, is required for slit diaphragm function and
assembly. Nephrin, the gene mutated in congenital ne-
phrotic syndrome of the Finnish type (NPHS1), encodes a
transmembrane protein of the Immunoglobulin superfam-
ily that is localized at the slit diaphragm joining the
interdigitated pedicles (Kestila et al., 1998). Mutations in
Nephrin cause severe proteinuria and usually lead to death
within the first 2 years of human life (Donoviel et al., 2001;
Kestila et al., 1998). Nephrin expression in humans and
mice has been detected in podocytes of the capillary loop
stage glomeruli, while in rats, Nephrin mRNA is already
present in S-shaped bodies (Kawachi et al., 2000; Putaala et
al., 2000). In addition, in the mouse, CD2 adapter protein
(CD2AP) has been identified as another component of the
slit diaphragm. CD2AP is a Src homology 3 domain-
containing protein that interacts directly with Nephrin and
is required for assembly of the slit diaphragm in the mouse
(Lehtonen et al., 2000; Li et al., 2000). In mutant mice
lacking CD2AP, podocyte foot processes form initially, but
begin to efface starting 1 week after birth. Podocin was
identified as the gene mutated in autosomal recessive
steroid-resistant nephrotic syndrome (NPHS2) on chromo-
some 1q25–31 and is first expressed at the capillary loop
stage. The Podocin protein is structurally related to the
integral membrane phosphoprotein stomatin.
We examined expression of these components of the slit
diaphragm in /, /krenu, and krenu/krenu kidneys by RNA
in situ hybridization and RNA slot blot analyses. We found
no difference in the temporal and spatial expression of
Nephrin, Podocin, or CD2AP between normal and krenu/
krenu kidneys (Figs. 5C–5J). Although the level of Podocin
expression was indistinguishable in the cranial ganglia of
normal, heterozygous, and homozygous mutant embryos at
15.5 dpc (data not shown), Podocin expression consistently
appeared lower in krenu/krenu kidneys. In RNA in situ
hybridization experiments, Podocin expression can nor-
mally be detected after 6–8 h of color development in
neonatal kidneys, but could be detected only upon 12–18 h
of color development in RNA in situ hybridization in
mutant kidneys, and even then the observed level appears
reduced (Figs. 5G–5J). We examined mRNA levels of Podo-
cin, Nephrin, and  Actinin 4 in RNA slot blots to deter-
mine whether these were affected in krenu/krenu mutants
(Figs. 6A and 6B). The levels of Nephrin and Podocin mRNA
appear slightly reduced in krenu/krenu kidneys. When we
quantified the levels of Nephrin and Podocin mRNA by
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densitometry, Podocin and Nephrin mRNA levels are re-
duced to 76  7 and 62  9%, respectively, in krenu
homozygotes relative to their heterozygous and / litter-
mates. Levels of  Actinin 4 RNA in neonatal kidneys
appear equivalent between krenu homozygotes, heterozy-
gotes, and unaffected littermates. By immunofluorescence
with anti-Podocin and anti-Nephrin antibodies, we deter-
mined that Podocin and Nephrin proteins are localized to
the membranes of both normal and krenu/krenu podocytes
(Figs. 6C–6E). Thus, transcription of Podocin and Nephrin
does not depend on active Kreisler homodimers, but indi-
rectly or directly, Kreisler may have a small effect on the
transcription or stability of Podocin and Nephrin mRNAs.
In the future, identification of direct Kreisler targets during
podocyte differentiation may reveal additional proteins
important in glomerular function and possibly in kidney
disease.
Kreisler Acts Downstream of the Pod1
Transcription Factor
To begin to dissect the transcriptional hierarchy that
governs podocyte differentiation, we examined the expres-
sion of Kreisler in mice homozygous for a mutation in the
basic helix–loop–helix transcription factor Pod1 (epicardin/
capsulin). Pod1 is expressed in mesenchymal tissues of the
developing kidney and in podocytes (Hidai et al., 1998; Lu
et al., 1998; Quaggin et al., 1998; Robb et al., 1998).
Disruption of Pod1 causes podocytes to remain columnar
shaped and to appear as though they are arrested in the
S-shaped stage. A few rare primitive foot processes can be
detected (Quaggin et al., 1999). This phenotype is signifi-
cantly more severe than that observed in krenu/krenu kidneys,
where overall glomerular differentiation appears to be un-
affected and podocytes do not appear columnar-shaped, but
are simply not developing foot processes. At present, it is
unclear whether the more severe phenotype in Pod1 mu-
tants is a consequence of the podocyte-specific role of Pod1
or because of a defect in mesenchymal cells that surround
the glomerulus (Quaggin et al., 1998). In krenu/krenu animals,
Pod1 was expressed normally in the podocytes of 15.5-dpc
and neonatal kidneys (Figs. 5K and 5L). However, when we
examined glomeruli from Pod1/ mutant mice, we could
not detect appreciable amounts of Kreisler protein in the
podocytes (Fig. 7). Taken together, these observations sug-
gest that Pod1 acts upstream of Kreisler in podocyte differ-
entiation and that Pod1 may have a podocyte-specific
cell-autonomous role.
DISCUSSION
Aside from Kreisler, a variety of other transcription
factors play important roles in glomerular development. All
of these appear to act at earlier stages of kidney develop-
ment or podocyte differentiation than Kreisler does. Ge-
netic experiments have implicated the Wilm’s tumor sup-
pressor gene, WT1, in podocyte development (Dressler et
al., 1993). Patients with Denys–Drash syndrome, which is
associated with specific heterozygous mutations of WT1,
are not only at increased risk for developing Wilm’s tumor,
but also develop a nephropathy associated with grossly
abnormal podocyte morphology (Pelletier et al., 1991). Mice
homozygous for a null allele of WT1 fail to develop kidneys;
therefore, a possible later role of WT1 in podocyte develop-
ment has not yet been assessed (Kreidberg et al., 1993). WT1
protein is detected in podocytes of the early comma-shaped
glomerulus well in advance of Kreisler expression and is
maintained throughout podocyte development and in ma-
ture podocytes. Our results would predict that the dediffer-
entiated tumorigenic state in Wilm’s tumors and in Denys–
Drash syndrome may be associated with down-regulation of
Kreisler. Assays of Kreisler expression might, in the future,
serve as prognosticators of tumor progression. In contrast to
humans, no increased occurrence of renal tumors is ob-
served in mice heterozygous for a WT1 null mutation, and
similarly we have not observed tumors or cysts in kidneys
from adult krenu heterozygotes.
As a bZip protein, Kreisler acts by forming complexes
with other transcription factors and other bZip proteins in
particular. At present, the only other bZip protein with a
known role in kidney development is EYA1, a mammalian
homologue of the eyes absent (eya) gene from Drosophila
melanogaster (Abdelhak et al., 1997). In humans, muta-
tions in EYA1 are responsible for the autosomal dominant
branchio-oto-renal (BOR) syndrome, which is characterized
by varying combinations of branchial, outer, middle, and
inner ear, and renal anomalies. In the mouse, Eya1/
animals show renal abnormalities and a conductive hearing
loss equivalent to human BOR syndrome, while Eya1/
mice lack ears and kidneys due to defective inductive tissue
interactions and apoptotic regression of the organ primordia
(Johnson et al., 1999; Xu et al., 1999). Eya1 expression is
observed in the condensing mesenchymal cells of the kid-
ney and consistent with the excretory and collecting sys-
tem anomalies of BOR syndrome. We and others have not
detected expression of EYA1 in mouse podocytes (data not
shown), nor have specific podocyte defects been reported in
BOR syndrome patients (Kalatzis et al., 1998). This lack of
coexpression in podocytes precludes a biologically relevant
interaction during glomerular development, and thus,
Kreisler is likely to interact with other as yet unidentified
proteins to regulate podocyte specific transcription.
Mutations in Lmx1b, which in humans are responsible
for nail patella syndrome, cause thickening and gaps in the
GBM and an apparent lack of foot processes (Chen et al.,
1998; Dreyer et al., 1998). Patients with nail patella syn-
drome, which is localized on chromosome 9q34, have a
significantly thickened GBM, and renal insufficiency with
proteinuria occurs in 30% of all patients. Lmx1b expression
commences in the S-shaped body, and thus, prior to that of
Kreisler. In the roof plate of the neural tube, Kreisler is
downstream of Lmx1a, which is mutated in the classical
mouse dreher mutation (Millonig et al., 2000). Taken
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FIG. 7. Kreisler protein is absent in kidneys in the podocytes of Pod1/ mice. While Kreisler protein is present in podocytes from mice
heterozygous for a mutation in Pod1 (A, C), it cannot be detected in podocytes from Pod1/ mice (B, D) by immunofluorescence with
anti-Kreisler antibody. All panels are shown at the same magnification. The scale bar represents 20 m. Normal (C) and krenu/krenu (D)
glomeruli that are shown in (A) and (B), respectively, were counter-stained with DAPI.
FIG. 8. Schematic diagram of podocyte differentiation. At the S-shaped stage of glomerular development, podocytes appear cuboidal and
in their appearance resemble those observed in Pod1/ mice. At this stage, Pod1 and Lmx1b are expressed. -Actinin 4 expression is also
seen at this stage. During the transition from the S-shaped to the capillary loop stage, the composition of the GBM changes. Lmx1b
regulates the expression of some of the components of the GBM. At the capillary loop stage, the GBM has fused, for the most part, into one
thick membrane. During maturation of the podocyte, the foot processes form on the outer GBM, until the GBM is completely fringed by
foot processes. During the capillary loop stage, podocytes begin to express Nephrin, Podocin, and CD2AP. In kidneys from mice
homozygous for the krenu mutation, foot processes cannot form because of a defect in podocyte differentiation. However, the GBM appears
electron-microscopically normal and Nephrin, Podocin, CD2AP, and -actinin 4 are expressed in these animals. The severity of the defect,
the appearance of the podocytes, and the time of expression all suggest that Kreisler acts directly or indirectly downstream of Pod1 and
Lmx1b, and indeed Kreisler protein can no longer be detected at normal levels in podocytes from Pod1/ mice. Electron microscopic
cross-section through a mature podocyte shows the foot processes extending from the podocyte cell body. Pc, podocyte (blue); c, capillary;
m, mesangial cell (solid black); blue denotes early GBM, which differs in its composition from the fused glomerular basement membrane
in the capillary loop stage, shown in red.
together, these observations suggest that Kreisler acts at a
later stage of podocyte differentiation and may be down-
stream, possibly directly, of Lmx1b. It is quite possible that
some of the roof plate-specific and podocyte-specific regu-
latory elements of Kreisler may overlap.
Our analyses have revealed that Kreisler acts downstream
of the Pod1 bHLH transcription factor. In Pod1/ mice,
glomerular maturation is arrested well before the podocyte-
specific expression of Kreisler would normally commence.
In Pod1/ mice, the podocytes appear columnar-shaped and
no foot processes form (Quaggin et al., 1999). In krenu
homozygotes, the morphology of podocytes appears normal,
but foot processes do not extend. Taken together, these
observations suggest that Kreisler is more likely to be an
indirect rather than a direct target of the Pod1 transcription
factor. Furthermore, Kreisler is required for the final stage
in podocyte differentiation, the progression through the
capillary loop stage to the mature glomerulus. Thus,
Kreisler regulates podocyte differentiation during the capil-
lary loop stage and governs such processes as either the
extension or attachment of the foot processes or possibly
the assembly of the filtration apparatus.
While we could assess the role of Kreisler in initial
podocyte differentiation, we could not analyze its role in
maintenance of functional podocytes or in recovery from
podocyte damage. For example, in neonatal kidneys,
Kreisler is not required for the initial production or fusion
of the GBM, and the GBM appears ultrastructurally normal.
However, Kreisler may play a role in the later podocyte-
specific generation of GBM in mature podocytes. Such a
role would only be uncovered during maturation and aging
of the animals. In that case, inactivation of Kreisler in adult
mice might cause severe nephrotic syndrome within 4–8
weeks or prevent animals from recovering after short-term
podocyte insults. Thus, conditional or inducible kidney-
specific alleles of Kreisler would be invaluable for further
understanding of podocyte development and renal disease.
The levels of two known components of the filtration
apparatus, Nephrin or Podocin, may be slightly reduced in
krenu homozygotes, but these genes are not likely to be
direct targets of Kreisler. This is especially true of Nephrin,
which has been detected in other animals in podocytes of
the S-shaped stage, and thus before the appearance of
Kreisler expression. The slightly reduced expression of
Podocin and Nephrin may reflect the reduced overall mem-
brane surface area of podocytes arrested at the capillary loop
stage. Thus, a dynamic feedback loop that senses the
surface area of the membrane may help regulate the amount
of these proteins.
The podocyte-specific target genes of Kreisler remain to
be identified. We expect most of these to be distinct from
those regulated by Kreisler in the hindbrain. For example,
we could not detect expression of Hoxa3 or Hoxb3, two
known Kreisler target genes in the hindbrain, in podocytes
at any stage of glomerular development (S.P.C., unpub-
lished observations; Mansour et al., 1988; Manzanares et
al., 1997). Conversely, we and others have not detected
expression of podocyte-specific genes in the fifth and sixth
rhombomeres of the embryonic hindbrain. The list of
known genes with podocyte-specific expression patterns
has been expanding rapidly, and testing each known
podocyte-specific gene for its expression in krenu mutants is
rapidly becoming a daunting task. Hence, podocyte-specific
targets of Kreisler may perhaps best be identified in future
subtractive hybridization or microarray experiments. Over-
all, our results suggest that such experiments would iden-
tify additional components important for podocyte function
and in human kidney disease.
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